Invesco’s Seres Therapeutics MCRB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-136,572
| Closed | -$95.6K | – | 3819 |
|
2025
Q1 | $95.6K | Buy |
136,572
+89,995
| +193% | +$63K | ﹤0.01% | 3616 |
|
2024
Q4 | $38.7K | Sell |
46,577
-8,641
| -16% | -$7.18K | ﹤0.01% | 3698 |
|
2024
Q3 | $52.2K | Buy |
55,218
+15,959
| +41% | +$15.1K | ﹤0.01% | 3669 |
|
2024
Q2 | $28.4K | Sell |
39,259
-23,707
| -38% | -$17.2K | ﹤0.01% | 3847 |
|
2024
Q1 | $48.7K | Buy |
62,966
+5,966
| +10% | +$4.62K | ﹤0.01% | 3790 |
|
2023
Q4 | $79.8K | Buy |
57,000
+13,642
| +31% | +$19.1K | ﹤0.01% | 3702 |
|
2023
Q3 | $103K | Buy |
43,358
+2,262
| +6% | +$5.38K | ﹤0.01% | 3698 |
|
2023
Q2 | $197K | Buy |
41,096
+6,069
| +17% | +$29.1K | ﹤0.01% | 3601 |
|
2023
Q1 | $199K | Buy |
35,027
+833
| +2% | +$4.72K | ﹤0.01% | 3599 |
|
2022
Q4 | $191K | Sell |
34,194
-535,403
| -94% | -$3M | ﹤0.01% | 3674 |
|
2022
Q3 | $3.66M | Buy |
569,597
+538,849
| +1,752% | +$3.46M | ﹤0.01% | 2368 |
|
2022
Q2 | $106K | Sell |
30,748
-978
| -3% | -$3.37K | ﹤0.01% | 3846 |
|
2022
Q1 | $225K | Sell |
31,726
-3
| -0% | -$21 | ﹤0.01% | 3714 |
|
2021
Q4 | $264K | Sell |
31,729
-8,520
| -21% | -$70.9K | ﹤0.01% | 3629 |
|
2021
Q3 | $281K | Buy |
40,249
+6,604
| +20% | +$46.1K | ﹤0.01% | 3642 |
|
2021
Q2 | $802K | Buy |
33,645
+19,087
| +131% | +$455K | ﹤0.01% | 3194 |
|
2021
Q1 | $300K | Buy |
14,558
+4,169
| +40% | +$85.9K | ﹤0.01% | 3530 |
|
2020
Q4 | $254K | Sell |
10,389
-63,556
| -86% | -$1.55M | ﹤0.01% | 3443 |
|
2020
Q3 | $2.09M | Buy |
+73,945
| New | +$2.09M | ﹤0.01% | 2469 |
|